Cargando…
Case Report: Ribociclib-induced phototoxicity presented as dyschromia with subsequent bullae formation
Ribociclib, a cyclin-dependent kinase 4/6 inhibitor, is a novel targeted therapy for advanced-stage breast cancer. Although ribociclib-induced cutaneous side effects have been previously noted, they have not been well documented. Herein, we present a case of ribociclib-induced phototoxicity, which m...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484504/ https://www.ncbi.nlm.nih.gov/pubmed/37692847 http://dx.doi.org/10.3389/fonc.2023.1184738 |